The repeatability of interleukin-6, tumor necrosis factor-α, and C-reactive protein in COPD patients over one year

References

• Global Initiative for Chronic Obstructive Lung Disease (GOLD)2007Accessed March 28, 2007 Available from http://www.goldcopd.com
   Google Scholar
• BroekhuizenRWoutersEFCreutzbergECScholsAMRaised CRP levels mark metabolic and functional impairment in advanced COPDThorax2006611172216055618
   PubMed Web of Science ®Google Scholar
• YendeSWatererGWTolleyEAInflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjectsThorax2006611101616284220
   PubMed Web of Science ®Google Scholar
• EidAAIonescuAANixonLSInflammatory response and body composition in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med20011648 Pt 11414141811704588
   PubMed Web of Science ®Google Scholar
• AgustiAGSauledaJMirallesCSkeletal muscle apoptosis and weight loss in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2002166448548912186825
   PubMed Web of Science ®Google Scholar
• SinDDManSFWhy are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary diseaseCirculation2003107111514151912654609
   PubMed Web of Science ®Google Scholar
• JorgensenNRSchwarzPHolmeIHenriksenBMPetersenLJBackerVThe prevalence of osteoporosis in patients with chronic obstructive pulmonary disease: a cross sectional studyRespir Med2007101117718516677808
   PubMed Web of Science ®Google Scholar
• ScholsAMBuurmanWAStaal van den BrekelAJDentenerMAWoutersEFEvidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary diseaseThorax19965188198248795671
   PubMed Web of Science ®Google Scholar
• de GodoyIDonahoeMCalhounWJMancinoJRogersRMElevated TNF-alpha production by peripheral blood monocytes of weight-losing COPD patientsAm J Respir Crit Care Med199615326336378564110
   PubMed Web of Science ®Google Scholar
• GanWQManSFSenthilselvanASinDDAssociation between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysisThorax200459757458015223864
   PubMed Web of Science ®Google Scholar
• TakabatakeNNakamuraHAbeSCirculating leptin in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med19991594 Pt 11215121910194168
   PubMed Web of Science ®Google Scholar
• HigashimotoYYamagataYTayaSSystemic inflammation in chronic obstructive pulmonary disease and asthma: Similarities and differencesRespirology200813112813318197923
   PubMed Web of Science ®Google Scholar
• DahlMVestboJLangePBojesenSETybjaerg-HansenANordestgaardBGC-reactive protein as a predictor of prognosis in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2007175325025517053205
   PubMed Web of Science ®Google Scholar
• ManSFConnettJEAnthonisenNRWiseRATashkinDPSinDDC-reactive protein and mortality in mild to moderate chronic obstructive pulmonary diseaseThorax2006611084985316738034
   PubMed Web of Science ®Google Scholar
• PearsonTAMensahGAAlexanderRWMarkers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart AssociationCirculation2003107349951112551878
   PubMed Web of Science ®Google Scholar
• RidkerPMRifaiNRoseLBuringJECookNRComparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular eventsN Engl J Med2002347201557156512432042
   PubMed Web of Science ®Google Scholar
• Pinto-PlataVMMullerovaHTosoJFC-reactive protein in patients with COPD, control smokers and non-smokersThorax2006611232816143583
   PubMed Web of Science ®Google Scholar
• KishimotoTThe biology of interleukin-6Blood19897411102473791
   PubMed Web of Science ®Google Scholar
• GarrodRMarshallJBarleyEFredericksSHaganGThe relationship between inflammatory markers and disability in chronic obstructive pulmonary disease (COPD)Prim Care Respir J200716423624017665081
   PubMedGoogle Scholar
• KunisakiKMRiceKLJanoffENRectorTSNiewoehnerDEExhaled nitric oxide, systemic inflammation, and the spirometric response to inhaled fluticasone propionate in severe chronic obstructive pulmonary disease: a prospective studyTher Adv Respir Dis200822556419124359
   PubMedGoogle Scholar
• TakabatakeNNakamuraHAbeSThe relationship between chronic hypoxemia and activation of the tumor necrosis factor-alpha system in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med20001614 Pt 11179118410764309
   PubMed Web of Science ®Google Scholar
• Di FranciaMBarbierDMegeJLOrehekJTumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med19941505 Pt 1145314557952575
   PubMed Web of Science ®Google Scholar
• KaradagFKarulABCildagOYilmazMOzcanHBiomarkers of systemic inflammation in stable and exacerbation phases of COPDLung2008186640340918807087
   PubMed Web of Science ®Google Scholar
• LeeTMLinMSChangNCUsefulness of C-reactive protein and interleukin-6 as predictors of outcomes in patients with chronic obstructive pulmonary disease receiving pravastatinAm J Cardiol2008101453053518312772
   PubMed Web of Science ®Google Scholar
• BeehKMBeierJKornmannOManderABuhlRLong-term repeatability of induced sputum cells and inflammatory markers in stable, moderately severe COPDChest2003123377878312628878
   PubMed Web of Science ®Google Scholar
• BalzanoGStefanelliFIorioCEosinophilic inflammation in stable chronic obstructive pulmonary disease. Relationship with neutrophils and airway functionAm J Respir Crit Care Med19991605 Pt 11486149210556110
   PubMed Web of Science ®Google Scholar
• BrightlingCEMonterioWGreenRHInduced sputum and other outcome measures in chronic obstructive pulmonary disease: safety and repeatabilityRespir Med20019512999100211778799
   PubMed Web of Science ®Google Scholar
• BoorsmaMLutterRvan de PolMAOutTAJansenHMJonkersRERepeatability of inflammatory parameters in induced sputum of COPD patientsCOPD20074432132918027159
   PubMedGoogle Scholar
• PelemanRARytilaPHKipsJCJoosGFPauwelsRAThe cellular composition of induced sputum in chronic obstructive pulmonary diseaseEur Respir J199913483984310362050
   PubMed Web of Science ®Google Scholar
• BlandJMAltmanDGStatistical methods for assessing agreement between two methods of clinical measurementLancet1986184763073102868172
   PubMed Web of Science ®Google Scholar
• SevenoaksMJStockleyRAChronic Obstructive Pulmonary Disease, inflammation and co-morbidity – a common inflammatory phenotype?Respir Res200677016669999
   PubMed Web of Science ®Google Scholar
• ReidMBLiYPTumor necrosis factor-alpha and muscle wasting: a cellular perspectiveRespir Res20012526927211686894
   PubMed Web of Science ®Google Scholar
• BemelmansMHvan TitsLJBuurmanWATumor necrosis factor: function, release and clearanceCrit Rev Immunol19961611118809470
   PubMed Web of Science ®Google Scholar
• Diez-RuizATilzGPZangerleRBaier-BitterlichGWachterHFuchsDSoluble receptors for tumour necrosis factor in clinical laboratory diagnosisEur J Haematol1995541187859870
   PubMed Web of Science ®Google Scholar
• LandboCPrescottELangePVestboJAlmdalTPPrognostic value of nutritional status in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med199916061856186110588597
   PubMed Web of Science ®Google Scholar
• ScholsAMSlangenJVolovicsLWoutersEFWeight loss is a reversible factor in the prognosis of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med19981576 Pt 1179117979620907
   PubMed Web of Science ®Google Scholar
• KaradagFKirdarSKarulABCeylanEThe value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary diseaseEur J Intern Med200819210410818249305
   PubMed Web of Science ®Google Scholar
• VestboJPrescottEAlmdalTBody mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart StudyAm J Respir Crit Care Med20061731798316368793
   PubMed Web of Science ®Google Scholar
• SapeyEBayleyDAhmadANewboldPSnellNStockleyRAInter-relationships between inflammatory markers in patients with stable COPD with bronchitis: intra-patient and inter-patient variabilityThorax200863649349918057097
   PubMed Web of Science ®Google Scholar
• SinDDManSFMarciniukDDThe effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2008177111207121418310480
   PubMed Web of Science ®Google Scholar